Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 99,945

Document Document Title
WO/2018/006939A1
The present invention refers to aninactivated isolated microorganism belonging to the Mycobacterium tuberculosis complex that comprises the deletion or previous disruption of the phoP gene; and a second gene to prevent DIM production. Al...  
WO/2018/009809A1
Compositions, methods and kits are provided. The compositions, methods and kits are for assembly of series of DNA segments in yeast using homologous recombination. The assembled DNA segments are maintained episomally. Yeast made using th...  
WO/2018/009703A1
Disclosed herein are methods and kits for identifying a subject as having breast cancer. Also provided herein are methods and kits for determining the prognosis of a subject having breast cancer and for determining the progression of bre...  
WO/2018/009372A1
The present disclosure provides novel bacterial strains with altered expression or start codon modification of one or more RNA degradation/processing genes. The RNA degradation genes of the present disclosure are controlled by heterologo...  
WO/2018/009335A1
We found that bacterial spores could be pretreated or initially treated with a partial complement of germinants (i.e., less germinants than would cause germination) and, subsequently, could be treated with the remaining germinants to cau...  
WO/2018/009863A1
Provided are compositions and methods for making a diploid yeast having heterozygosity for at least one chromosome. The method includes mating haploid yeast having at least a first modified chromosome comprising a synthetic chromosome su...  
WO/2018/008786A1
The present invention relates to a Thermococcus onnurineus 480T (deposit number: KCTC13046BP) strain, and a hydrogen producing method comprising: a step (a) of supplying carbon monoxide to the strain in claim 1 and culturing the same; an...  
WO/2018/003858A1
A cell enclosure device according to the present invention is a cell enclosure device for constructing a multicellular structure obtained by culturing cells, a porous membrane being provided to at least a portion of the cell enclosure de...  
WO/2018/005806A2
The present disclosure relates to biosynthetic pathways for producing flavor and fragrance chemicals, such as green notes including trans-2-unsaturated aldehydes and lactones. The present disclosure provides methods for producing trans-2...  
WO/2018/004224A3
The present invention relates to an Epidermidibacterium gen. strain, which belongs to Sporichthyaceae, a culture medium thereof, or a composition containing the same for improving a skin condition or for preventing or treating an inflamm...  
WO/2018/005493A2
Disclosed herein are engineered bacteria that manufacture biofilms from bacterial amyloid structures known as curli fibers. These biofilms and biofilm matrices are capable immobilizing enzymes and generating catalytic surfaces.  
WO/2018/004014A1
The invention provides an active microbial transglutaminase (MTG) that does not require protease treatment in a protein expression system using a universal host such as Escherichia coli, that is, an MTG mutant having transglutaminase act...  
WO/2018/005934A1
Methods and compositions are provided for conversion of gaseous alkenes to liquid diols via biological or enzymatic means.  
WO/2018/002270A1
The present invention relates to the field of native outer membrane vesicles (n OMVs), particularly n OMVs having increased levels of lipoproteins on their surface and use of same in immunogenic compositions.  
WO/2018/004224A2
The present invention relates to an Epidermidibacterium gen. strain, which belongs to Sporichthyaceae, a culture medium thereof, or a composition containing the same for improving a skin condition or for preventing or treating an inflamm...  
WO/2018/004016A1
Provided are: a Pseudozyma churashimaensis RGJ1 strain, which is isolated from a pepper plant body and induces induced systemic resistance to plant body pathogens or plant viruses; a microbial preparation for controlling plant diseases o...  
WO/2018/000089A1
Polynucleotides and polypeptides useful in the manufacture of a class of chemical compounds known as alkaloids are provided. The polynucleotides and polypeptides may be used to synthesize alkaloids, including reticuline, thebaine and mor...  
WO/2018/002059A1
The invention relates to a microalga which is genetically modified by inhibiting the Δ0 elongase (Δ0-ELO) enzyme activity, using palmitic acid, a saturated fatty acid, as a substrate, and which is associated with the production of mono...  
WO/2018/006104A1
The invention relates to a biological composition that stimulates Aquilaria spp. to induce agarwood. This inoculant contains 50% prepared by the fungal strain Collectotrichum sp. (TH1) and 50% prepared by the bacterial strain Pseudomonas...  
WO/2018/004010A1
In order to provide a device for thawing preserved vitrified germ cells and a thawing method that simultaneously realize a high conception rate and facilitate transplantation work, the device for thawing (1) is equipped with a mounting d...  
WO/2018/002581A1
A method of reducing the level of RNA in a biomass comprising filamentous fungus involves the following steps: (i) heating the biomass, downstream of the fermenter to a first temperature in the range 40- 69°C; (ii) heating the biomass t...  
WO/2018/002520A1
Use of a selenised compound for increasing the ethanol content of a composition, said process comprising at least one step for the alcoholic fermentation of said composition carried out in the presence of said selenised compound in a con...  
WO/2018/002248A1
The present invention relates to the field of preservation of microorganisms, and in particular provides a 2-compartment system comprising a first compartment comprising microcapsules with microorganisms in a non-aqueous composition in t...  
WO/2018/004586A1
The present invention discloses the use of probiotics for therapeutic management of major depressive disorder (MDD). Specifically, the invention discloses the method of therapeutically managing MDD in mammals with Irritable bowel syndrom...  
WO/2018/000043A1
The present invention relates to a cell coated with a layer of crystalline Metal Organic Framework (MOF).  
WO/2018/003641A1
Provided is an improvement in C4 dicarboxylic acid productivity in a host cell. A polypeptide that comprises the amino acid sequence represented by SEQ ID NO:2 or an amino acid sequence having 90% or more sequence identity to the aforesa...  
WO/2018/005604A1
The present invention provides a method for inhibiting the growth of food-borne pathogens, nosocomial pathogens and spoilage microorganisms, the method comprising the steps of: contacting at least one lactic acid bacterium strain selecte...  
WO/2018/005655A2
The present disclosure describes methods for generating microbial strains expressing a heterologous bacterial hemoglobin gene that produce biomolecules of interest. In aspects, the disclosure provides novel bacterial strains, which expre...  
WO/2018/002579A1
A method of reducing the level of RNA in a biomass comprising filamentous fungus involves the following steps: (i)heating the biomass, downstream of the fermenter to a first temperature in the range 40- 69°C; (ii)heating the biomass to ...  
WO/2018/002331A1
Provided herein is a composition comprising: a) about 25% up to about 75% of a plasmolysed micro-organism by weight of the total weight of the composition; b) about at least greater than 20% up to about 60% by weight flavor or fragrance,...  
WO/2018/005599A3
The present invention provides a method for inhibiting the growth of pathogens in an animal feed comprising the steps of: contacting an animal feed with at least one lactic acid bacterium strain selected from the group consisting of Lact...  
WO/2017/223501A1
Methods for spray drying gram negative bacteria are provided. Such spray drying methods are performed under conditions that allow for the spray dried composition to retain the biological activity of interest of the gram-negative bacteria...  
WO/2017/223273A1
In certain aspects, described herein are methods, bacteria, and compositions for the reduction of the amount, activity and/or proliferation of colonic group 3 innate lymphoid cells (ILC3s) and for the treatment and/or prevention of disea...  
WO/2017/222142A1
The present invention provides Bacillus licheniformis strain NY1505 (accession number KCTC13021BP) for a high yield of an α-glucosidase inhibitor. Bacillus licheniformis strain NY1505, according to the present invention, is a novel stra...  
WO/2017/223364A1
The inventions disclosed herein relate to the findings that Lactobacillus reuteri (L. reuteri) bacteria isolated from dog saliva is capable of modulating a subject's body weight. In certain aspects, the inventions disclosed herein relate...  
WO/2017/221873A1
The present invention provides a mutant coleoptera luciferase, which has a mutation of, in the amino acid sequence of wild type North America firefly luciferase among amino acid sequences encoding wild type coleoptera luciferases, substi...  
WO/2017/219455A1
The present invention provides a gene for encoding a truncated human keratinocyte growth factor. The gene is one of the following nucleotide sequences: 1) the sequence with SEQ ID No:1 in a sequence list; and 2) a DNA sequence that has a...  
WO/2017/223569A1
The present invention provides for a composition comprising: (a) a first host cell capable of producing L-DOPA; and (b) a modified host cell is capable of converting L-DOPA into hydroxytyrosol (HTy); wherein any one or both of the first ...  
WO/2017/223538A1
Provided herein are methods and composition for trackable genetic variant libraries. Further provided herein are methods and compositions for recursive engineering. Further provided herein are methods and compositions for multiplex engin...  
WO/2017/221559A1
The invention is intended to metabolize acetic acid in a medium at the time of culture, such as ethanol fermentation by yeast, and to reduce acetic acid concentration. Specifically, the invention relates to a recombinant yeast resultin...  
WO/2017/221591A1
Provided are a cell processing system and a cell supply method whereby a cell in a desired state can be provided at an appropriate time. A cell processing system (10) is provided with a plurality of culture units (15). Each of the cultur...  
WO/2017/221765A1
A microorganism that has 16S rRNA gene containing any of nucleic acids (a)-(c) and is capable of degrading a lignocellulose-based biomass: (a) a nucleic acid having a base sequence represented by SEQ ID NO: 1 or 2; (b) a nucleic acid hav...  
WO/2017/222141A1
The present invention provides a Bacillus subtilis strain (accession number KCTC13020BP) enabling a high yield of thrombolytic enzymes. A Bacillus subtilis strain GDN, according to the present invention, shows notably high thrombolytic e...  
WO/2017/222034A1
The present invention is a modified fibroin including a domain sequence represented by formula 1: [(A)n motif-REP]m, wherein, compared to a fibroin derived from nature, the domain sequence contains an amino-acid sequence that locally inc...  
WO/2017/221905A1
[Problem] To provide a β-glucan-producing fungus without a melanin pigment formation ability or with a low melanin pigment formation ability, which is mutated from a common β-glucan-producing fungus, does not have a melanin pigment for...  
WO/2017/219159A1
The invention relates to an algae filter and bioreactor for individual use, characterised in that it comprises a container (7) of culture medium and a mini water pump (10) that recirculates the culture medium, the medium being pumped thr...  
WO/2017/223025A1
The invention provides genetically engineered microorganisms useful for the production of butyrate. The bacterium of the invention comprises inactivation/deletion of genes encoding lactate dehydrogenase (ldhA) and alcohol dehydrogenase (...  
WO/2017/219987A1
Provided is a Schizochytrium limacinum mutant strain. The Schizochytrium limacinum mutant strain was deposited in the China Centre for Type Culture Collection (CCTCC) with a deposit number of CCTCC NO: M2012494 on 03 December 2012, and t...  
WO/2017/217460A1
A fusion protein containing at least two proteins, said fusion protein being characterized in that the at least two proteins are fused to each other through a peptide linker having the following amino acid sequence: Xm(PYn)qPZr. In the a...  
WO/2017/217753A1
The present invention relates to a strain of the genus Agathobaculum having an effect of preventing or treating degenerative brain diseases, and a use thereof. Since the intestinal microorganism strain of Agathobaculum butyriciproducens ...  

Matches 101 - 150 out of 99,945